Rocketvax

Developer of therapeutic solutions for the treatment of SARS-CoV-2

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2020 groups6 employees language rocketvax.com

Social engagement

Social engagement: 1.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Ursimone Wietlisbach Foundation.

Investor typeCountShare
Other / undisclosed4100%

Recent activity

11 Dec 2025
Event
NCCR RNA & Disease Final Symposium
Coming soon